Healthy Eating for Aging

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Pennington Biomedical Research Center

Trial Summary

What is the purpose of this trial?

The purpose of this study is to conduct a five-arm pilot and feasibility trial in healthy, young individuals without obesity to evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Eligibility Criteria

The DiAL Health Research Study is for healthy individuals aged 25-45 with a BMI between 22 and below 30, who have maintained a stable weight recently, wake up early, and don't use chronic medications. Excluded are those with serious health conditions, pregnant or lactating women, heavy smokers or drinkers, extreme athletes, and people with unconventional eating habits.

Inclusion Criteria

Your body mass index (BMI) is between 22 and 30, which is considered a healthy weight range.

Stable body weight (less than ± 2kg) in the past 6 months

Regularly wake up between 5-8 AM

Exclusion Criteria

Depression as determined by the Beck Depression Inventory-II > 19

Pregnant, postpartum (< 12 months) or lactating females or attempting to become pregnant in the next 7 months

My bone density test shows a score lower than -2.0 in my hip or spine.

Participant Groups

This study tests the effectiveness of different dietary interventions aimed at slowing aging processes in young adults without obesity. It's a pilot trial with five groups to see which diet might help improve treatment compliance and support weight loss while promoting healthier aging.

Group I: Traditional CR Active Control 1 Intervention

A 25% calorie restriction (CR) intervention delivered via traditional in-person sessions.

Group II: Adaptive CR Active Control 1 Intervention

A 25% calorie restriction (CR) intervention delivered via a remote, adaptive, and technology-driven intervention program.

Group III: Traditional TRE Active Control 1 Intervention

An eight-hour time restricted eating (TRE) intervention delivered via traditional in-person sessions.

Group IV: Adaptive TRE Active Control 1 Intervention

An eight-hour time restricted eating (TRE) intervention delivered via a remote, adaptive, and technology driven intervention program.

Group V: ad libitum Control Placebo Group 1 Intervention

No treatment control condition.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Pennington Biomedical Research Center Baton Rouge, LA

Who Is Running the Clinical Trial?

Pennington Biomedical Research Center Lead Sponsor

References